Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/13/2025

Cetirizine and Levocetirizine Comparison

Clinical Efficacy and Safety

  • The American Academy of Allergy, Asthma, and Immunology recommends that cetirizine 10 mg may cause mild drowsiness in 13.7% of patients versus 6.3% with placebo 1
  • The British Association of Dermatologists suggests that both cetirizine and levocetirizine doses should be halved in moderate renal impairment, and avoided in severe renal impairment (creatinine clearance <10 mL/min) 2
  • The FDA categorizes both cetirizine and levocetirizine as Pregnancy Category B drugs, and recommends avoiding all antihistamines in pregnancy, especially in the first trimester 2

Special Population Considerations

  • The National Kidney Foundation recommends that cetirizine and levocetirizine doses should be adjusted in patients with renal impairment, with a recommended dose reduction of 50% in moderate renal impairment 2
  • The American College of Obstetricians and Gynecologists recommends that cetirizine and levocetirizine should be used with caution in pregnancy, and only when the benefits outweigh the risks 2